Why This Synthetic Biology Stock Has Doubled Since IPO
Synthetic biology startups dig for gold. Twist Bioscience is selling them millions of tiny shovels. Twist went public on October 30, 2019, at $14 a share. Since then, it has doubled to $28 dollars a share. Why has its stock doubled?